Clinical Trial Update: HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HSV-2 suppression to reduce HIV-1 levels in men co-infected with HIV-1 and HSV-2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Simplex Virus Infection

Snippet

Sponsor: University of Washington | Conditions: HIV Infection, Herpes Simplex | Phase 3 | Status: COMPLETED